Business Context and Reporting Period
Company: Omega Healthcare Investors, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001
Business Overview: The Company is a Real Estate Investment Trust (REIT) specializing in healthcare-related real estate, including long-term care facilities, rehabilitation hospitals, and mortgage loans. As of September 30, 2001, the portfolio consisted of 246 healthcare facilities in 29 states, with 60 facilities classified as "Owned and Operated" assets following foreclosures or restructurings.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2001 | Nine Months Ended Sep 30, 2001 | Nine Months Ended Sep 30, 2000 |
|---|---|---|---|
| Total Revenues | $66.8 million | $201.7 million | $195.7 million |
| Net Loss | $(1.9) million | $(11.3) million | $(47.0) million |
| Net Loss Available to Common | $(6.9) million | $(26.2) million | $(57.5) million |
| Loss Per Share (Basic/Diluted) | $(0.34) | $(1.31) | $(2.87) |
| Cash from Operating Activities | N/A | $7.4 million | $0.8 million |
| Total Assets | $911.3 million | $911.3 million | $948.5 million (Dec 31, 2000) |
| Total Liabilities | $454.6 million | $454.6 million | $484.1 million (Dec 31, 2000) |
| Stockholders' Equity | $456.7 million | $456.7 million | $464.3 million (Dec 31, 2000) |
| Debt Outstanding | $426.0 million | $426.0 million | N/A |
Liquidity: Cash and cash equivalents totaled $14.1 million as of September 30, 2001. The Company has two secured revolving credit facilities totaling $250 million, with $203.6 million outstanding. However, covenant violations have restricted access to remaining availability.
Material Changes vs. Prior Period
- Revenue: Nine-month revenues increased by $6.0 million compared to the prior year, driven primarily by a $10.2 million increase in nursing home revenues from Owned and Operated assets (due to the inclusion of 30 facilities formerly operated by RainTree Healthcare for the full period). This was partially offset by decreases in rental income ($4.0 million) and mortgage interest income ($1.5 million) due to foreclosures, bankruptcies, and asset sales.
- Expenses: Total expenses decreased significantly by $38.0 million for the nine-month period compared to 2000. This improvement is largely attributable to the absence of a $54.3 million provision for impairment and a $12.1 million provision for uncollectable accounts recorded in the prior year.
- Net Loss: The net loss for the nine months ended September 30, 2001, was $11.3 million, a substantial improvement from the $47.0 million loss in the same period in 2000.
- Dividends: The Company suspended all common and preferred dividends on February 1, 2001, to preserve cash for debt maturities. No dividends were paid in the first three quarters of 2001, compared to $0.75 per share paid in the same period in 2000.
Guidance, Outlook, Risks, and Unusual Items
Unusual Items
- Litigation Settlement: The Company recorded a $10.0 million litigation settlement expense in the second quarter of 2001 to resolve a suit with Karrington Health, Inc. This charge contributed to a violation of financial covenants in the Company's credit facilities.
- Impairment: An $8.4 million provision for impairment was recorded for the nine-month period, relating to assets held for sale recovered from a defaulting operator.
- Derivative Accounting: Charges of $1.1 million were recorded for derivative accounting related to interest rate swaps under FASB No. 133.
Liquidity and Capital Resources
- Debt Maturities: The Company faces significant debt maturities in 2002, totaling approximately $238.6 million, including $99.6 million in notes due in June 2002 and $139 million on credit facilities expiring in December 2002.
- Covenant Violations: The Karrington settlement caused a violation of financial covenants. While a waiver was obtained for the $175 million facility through December 13, 2001, the waiver for the $75 million facility has expired. Discussions with lenders are ongoing, but the Company cannot currently draw on remaining credit availability.
- Equity Raise: On October 30, 2001, the Company announced a plan to raise $50 million in new equity via a rights offering and a private placement with Explorer Holdings, L.P. This is contingent on obtaining amendments to credit facilities and waivers for covenant non-compliance.
Risks
- Refinancing Risk: There is no assurance the Company can refinance 2002 debt maturities on favorable terms or at all. Failure to do so could force disadvantageous asset sales or dilutive equity financing.
- Operational Risk: The Company operates 60 facilities directly, exposing it to regulatory compliance risks, reimbursement changes from Medicare/Medicaid, and occupancy fluctuations.
- Concentration Risk: Seven public operators control approximately 73.7% of the Company's investments, creating significant exposure to the financial health of these specific operators.
Investor Verification Checklist
- Covenant Waivers: Verify the status of negotiations with lenders regarding the expired waiver for the $75 million credit facility and the extension of the waiver for the $175 million facility.
- Equity Offering Status: Confirm whether the $50 million rights offering and private placement with Explorer Holdings, L.P. have been successfully closed and if the necessary credit facility amendments were obtained.
- Debt Refinancing: Assess the Company's progress in securing financing for the $238.6 million of debt maturing in 2002.
- Asset Dispositions: Monitor the sale of "Assets Held for Sale" ($7.4 million carrying value) and the performance of the 60 "Owned and Operated" facilities, which currently generate a net operating loss.
- Dividend Arrears: Note that $14.9 million in preferred dividends are in arrears and must be paid in full before common dividends can resume.